In Case You Missed It: Webinar on Safety Assessment of Gene Therapy Products
If you missed our latest webinar titled Nonclinical Safety Assessment of Gene Therapy Products, it’s not too late! The on-demand version is now available.
Topics covered include:
• current trends in the development of gene therapy products;
• timing of biodistribution studies based on the ICH S12 Guideline;
• planning considerations and requirements for toxicity studies; and
• AAVs NAbs pre-dose screening data for animal selection.
If you have questions about your nonclinical cell and gene therapy studies, speak with one of our experts.
You may also be interested in:
eBook: Key Considerations for Cell and Gene Therapy Nonclinical Studies
Scientific Poster: Gene Therapy Utilizing Adeno-Associated Viral (AAV) Vectors
Scientific Journal: Applications of PCR Analysis for Your Gene Therapy Programs